Matthew O'Brien
Stock Analyst at Piper Sandler
(0.07)
# 4,365
Out of 4,408 analysts
1249
Total ratings
36.7%
Success rate
-8.1%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintained: Buy | $75 → $88 | $74.22 | +18.57% | 66 | Jun 15, 2026 | |
| PODD Insulet | Maintained: Buy | $210 | $148.14 | +41.76% | 38 | Jun 15, 2026 | |
| GMED Globus Medical | Maintained: Buy | $115 → $100 | $77.32 | +29.33% | 55 | Jun 15, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $90 → $65 | $46.76 | +39.01% | 61 | Jun 12, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $38 | $32.82 | +15.78% | 4 | Jun 11, 2026 | |
| MMED MiniMed Group | Reiterated: Hold | $16 | $15.00 | +6.67% | 2 | Jun 4, 2026 | |
| CARL Carlsmed | Reiterated: Buy | $18 | $11.05 | +62.90% | 5 | Jun 3, 2026 | |
| TMDX TransMedics Group | Reiterated: Hold | $120 → $63 | $75.48 | -16.53% | 37 | Jun 2, 2026 | |
| BBNX Beta Bionics | Maintained: Buy | $20 | $14.38 | +39.08% | 10 | May 22, 2026 | |
| MDT Medtronic | Reiterated: Hold | $91 | $80.38 | +13.21% | 57 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $18.12 | +4.86% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.80 | +25.00% | 26 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $3.97 | +126.70% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.98 | +140.96% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $20.41 | +47.02% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $16.76 | +96.90% | 34 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $14 | $8.29 | +68.88% | 37 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $27.88 | +79.34% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $97 | $90.85 | +6.77% | 14 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $420 | $307.94 | +36.39% | 53 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $18.15 | +21.21% | 29 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 | $34.16 | +14.17% | 41 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $35 | $23.22 | +50.73% | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.7607 | +294.37% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $15.12 | +65.34% | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $318.21 | +17.53% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $88.26 | - | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $5.02 | n/a | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $28.37 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $130.09 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $11 | $3.93 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $180 | $130.14 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $4.60 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $1.07 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $44 | $17.46 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $90 | $0.0001 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $0.97365 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $1.27 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 | $20.81 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $79 | $66.94 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $26.36 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $3.87 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $435 | $67.76 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $1.05 | n/a | 10 | Jan 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $79.70 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 → $345 | $178.26 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 → $633 | $416.55 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $6.96 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.68 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $6.46 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $10.14 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $192.74 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.4491 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.94 | n/a | 2 | May 8, 2012 |
DexCom
Jun 15, 2026
Maintained: Buy
Price Target: $75 → $88
Current: $74.22
Upside: +18.57%
Insulet
Jun 15, 2026
Maintained: Buy
Price Target: $210
Current: $148.14
Upside: +41.76%
Globus Medical
Jun 15, 2026
Maintained: Buy
Price Target: $115 → $100
Current: $77.32
Upside: +29.33%
Boston Scientific
Jun 12, 2026
Maintained: Buy
Price Target: $90 → $65
Current: $46.76
Upside: +39.01%
HeartFlow
Jun 11, 2026
Reiterated: Buy
Price Target: $38
Current: $32.82
Upside: +15.78%
MiniMed Group
Jun 4, 2026
Reiterated: Hold
Price Target: $16
Current: $15.00
Upside: +6.67%
Carlsmed
Jun 3, 2026
Reiterated: Buy
Price Target: $18
Current: $11.05
Upside: +62.90%
TransMedics Group
Jun 2, 2026
Reiterated: Hold
Price Target: $120 → $63
Current: $75.48
Upside: -16.53%
Beta Bionics
May 22, 2026
Maintained: Buy
Price Target: $20
Current: $14.38
Upside: +39.08%
Medtronic
May 19, 2026
Reiterated: Hold
Price Target: $91
Current: $80.38
Upside: +13.21%
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $18.12
Upside: +4.86%
May 13, 2026
Reiterated: Hold
Price Target: $1
Current: $0.80
Upside: +25.00%
May 13, 2026
Maintained: Buy
Price Target: $15 → $9
Current: $3.97
Upside: +126.70%
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $4.98
Upside: +140.96%
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $20.41
Upside: +47.02%
May 8, 2026
Maintained: Buy
Price Target: $33
Current: $16.76
Upside: +96.90%
May 6, 2026
Maintained: Buy
Price Target: $25 → $14
Current: $8.29
Upside: +68.88%
May 6, 2026
Reiterated: Buy
Price Target: $50
Current: $27.88
Upside: +79.34%
May 1, 2026
Maintained: Buy
Price Target: $82 → $97
Current: $90.85
Upside: +6.77%
May 1, 2026
Maintained: Buy
Price Target: $420
Current: $307.94
Upside: +36.39%
May 1, 2026
Maintained: Buy
Price Target: $22
Current: $18.15
Upside: +21.21%
Apr 30, 2026
Reiterated: Hold
Price Target: $39
Current: $34.16
Upside: +14.17%
Apr 30, 2026
Maintained: Buy
Price Target: $28 → $35
Current: $23.22
Upside: +50.73%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.7607
Upside: +294.37%
Mar 23, 2026
Reiterated: Buy
Price Target: $25
Current: $15.12
Upside: +65.34%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $318.21
Upside: +17.53%
Oct 13, 2025
Maintained: Hold
Price Target: n/a
Current: $88.26
Upside: -
May 9, 2025
Maintained: Hold
Price Target: $3.5
Current: $5.02
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $16
Current: $28.37
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $130.09
Upside: n/a
Feb 14, 2025
Maintained: Hold
Price Target: $12 → $11
Current: $3.93
Upside: n/a
Jan 27, 2025
Maintained: Buy
Price Target: $140 → $180
Current: $130.14
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $4.60
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $1.07
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $55 → $44
Current: $17.46
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $10 → $90
Current: $0.0001
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $9 → $11
Current: $0.97365
Upside: n/a
Nov 9, 2021
Maintained: Buy
Price Target: $12 → $10
Current: $1.27
Upside: n/a
Sep 2, 2021
Maintained: Hold
Price Target: $82
Current: $20.81
Upside: n/a
Jul 30, 2021
Maintained: Buy
Price Target: $62 → $79
Current: $66.94
Upside: n/a
Jul 6, 2021
Maintained: Buy
Price Target: $70
Current: $26.36
Upside: n/a
Mar 23, 2021
Maintained: Hold
Price Target: $3.5
Current: $3.87
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $370 → $435
Current: $67.76
Upside: n/a
Jan 27, 2021
Maintained: Hold
Price Target: $7
Current: $1.05
Upside: n/a
Jan 12, 2021
Maintained: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $79.70
Upside: n/a
Jul 23, 2020
Maintained: Buy
Price Target: $258 → $345
Current: $178.26
Upside: n/a
Sep 25, 2019
Maintained: Buy
Price Target: $600 → $633
Current: $416.55
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $6.96
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $3.68
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $6.46
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $10.14
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $192.74
Upside: n/a
Aug 14, 2014
Maintained: Buy
Price Target: n/a
Current: $0.4491
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $7.94
Upside: n/a